Atlantis Bioscience is invested in meeting clinicians to address their translational research needs. As an innovation enabler, we are able to complete a smooth transition from bench-to-bed in many clinical applications. As a team, we are both passionate and pro-active in creating opportunities for our partners to strengthen R&D and translational capabilities through the marriage of relevant technologies and expertise. With a growing presence in Asia in our distribution and research activities, we provide clinicians with opportunities to expand their research repertoire by connecting them with like-minded partners who share similar goals.

Our key strengths are mainly cell therapy solutions, particularly in mesenchymal stem cells (MSC) and NK/T cells therapies.

Please reach out to us for any enquiries and collaborative work at

Tags: Atlantis Bioscience, bench-to-bed, Cell Therapy Solutions, Clinicians, Innovation enabler, MSC, NK/T Cells, R&D, Translational capabilities